CSI Market
Sign In | Register

Telomir Pharmaceuticals Inc (TELO) Annual Balance Sheets

Annual · GAAP · USD millions
Access TELO quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Telomir Pharmaceuticals Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent7.29
Cash & Short-term Investments7.00
Other Receivables0.00
Deferred Offering Costs DE0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.05
Total Current Assets7.34
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Total Assets7.34
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.54
Loans Payable, Current NO0.00
Other Liabilities, Current0.32
Total Current Liabilities1.43
Total Long-term Debt0.00
Due To Officer0.16
Accrued Compensation0.42
Total Liabilities1.43
Stockholders' Equity
Additional Paid In Capital Common Stock46.92
Retained Earnings / Accumulated Deficit-41.01
Common Stockholder's Equity5.91
Total Stockholder's Equity5.91
Liabilities & Stockholder's Equity7.34
4 historic quarters locked

Sign in to unlock the full Telomir Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Telomir Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 17, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-010625

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License